PSORIASIS ARTHRITIS
Clinical trials for PSORIASIS ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS ARTHRITIS trials appear
Sign up with your email to follow new studies for PSORIASIS ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could ozempic shield psoriatic arthritis patients from heart disease?
Disease control Not yet recruitingThis study tests whether semaglutide (Ozempic), a drug used for diabetes and weight loss, can slow the buildup of plaque in arteries of people with psoriatic arthritis who do not have diabetes. Forty participants will receive either semaglutide or no additional treatment for 24 w…
Matched conditions: PSORIASIS ARTHRITIS
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New study tracks psoriatic arthritis treatment success across therapy lines
Knowledge-focused Not yet recruitingThis observational study follows 400 adults with psoriatic arthritis who are starting a new biologic or targeted synthetic drug as part of their routine care. Researchers want to see if treatment response differs based on how many prior advanced therapies a person has tried, and …
Matched conditions: PSORIASIS ARTHRITIS
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Costa rica psoriasis study reveals hidden heart and joint risks
Knowledge-focused Not yet recruitingThis study will look at the health records of 350 people with psoriasis in Costa Rica to find out how many also have conditions like obesity, diabetes, high blood pressure, heart disease, or psoriatic arthritis. Researchers want to understand how these problems relate to psoriasi…
Matched conditions: PSORIASIS ARTHRITIS
Sponsor: Caja Costarricense de Seguro Social • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Costa rica launches registry to see how new psoriasis drugs work in real life
Knowledge-focused Not yet recruitingThis observational registry will follow 50 patients with psoriasis or psoriatic arthritis who are receiving IL-23 inhibitors (guselkumab or risankizumab) as part of their routine care in Costa Rica. Researchers will track how well the drugs improve skin and joint symptoms and qua…
Matched conditions: PSORIASIS ARTHRITIS
Sponsor: Caja Costarricense de Seguro Social • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC